Clinical trial Recruiting at 1 site Interventional Ages 50 to 75 Women only

Effects of Exercise on Fat Metabolism in Postmenopausal Women

Official title: Resistance Training Modulation of Fat Metabolism in Obese Postmenopausal Women

Run by Florida State University · NCT05351476 · Data updated 2026-11-12

This study tests whether resistance training or endurance training helps postmenopausal women who are obese and prediabetic improve their fat metabolism over 12 weeks.

More Obesity trials

Quick facts

Study typeInterventional
Ages50 Years to 75 Years
SexWomen only
Enrollment120 (estimated)
SponsorFlorida State University
Academic / other
Locations1 site (Tallahassee, Florida)
StatusRecruiting
StartedMay 20, 2022
Main results expectedApril 30, 2027
Study endsApril 30, 2027
Registry record updatedApril 13, 2026
Trial IDNCT05351476 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are sedentary postmenopausal women aged 50-75 with obesity and prediabetes.

Probably not a fit

Patients with type 1 or type 2 diabetes or those currently engaged in regular exercise may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates how resistance training compares to endurance training in improving fat metabolism among postmenopausal women who are obese and prediabetic. Over 12 weeks, participants will engage in either resistance or endurance exercises while their fat breakdown and synthesis responses are measured through various techniques, including microdialysis. The study aims to provide insights into the potential of resistance exercise as a practical approach to prevent type 2 diabetes in this population.

Why it matters

Potential benefit: If successful, this study could offer a new exercise-based strategy to help prevent type 2 diabetes in postmenopausal women.

How similar studies have gone: Other studies have shown positive outcomes with exercise interventions in similar populations, suggesting this approach has potential.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Women
* Postmenopausal (50-75 yrs.)
* Obese (BMI 30-50 kg/m2)
* Prediabetes (HbA1c 5.7 - 6.4% or fasting blood glucose 100 to 125 mg/dL, or 2hr OGTT blood glucose 140 to 199 mg/dL)
* Sedentary (not performing purposeful exercise training more than 20 minutes per day twice a week)
* Non-smokers
* No hormone replacement therapy for at least the past two years.

Exclusion Criteria:

* Engaging in purposeful resistance training or endurance training (\> 20min/day, \> 2 days/week)
* Resting blood pressure above 140 mmHg systolic or 90 mmHg diastolic
* Type 1 or type 2 diabetes
* Medical problems in which exercise is contraindicated, such as chronic infections
* History of, or currently presentation with, cancer, cardiovascular or respiratory disease
* Uncontrolled thyroid dysfunction, liver or renal dysfunction
* Taking any medication affecting lipid metabolism
* Musculoskeletal disease or injury that would otherwise prevent engagement in resistance and endurance training
* Smokers and those with diagnosed eating disorders

Where it's running

  • Florida State University
    Tallahassee, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Robert C Hickner, PhD — Florida State University
  • Study coordinator: Robert C Hickner, PhD
  • Email: rhickner@fsu.edu
  • Phone: 850-644-1375

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.